Feasibility & Acceptability of a Virtual Sister Circle Intervention for Black Women With Depressive Symptoms
Evaluating the Feasibility and Acceptability of a Therapeutically-Grounded Virtual Sister Circle Intervention for Black Women With Depressive Symptoms
1 other identifier
interventional
30
1 country
1
Brief Summary
The purpose of this study is to evaluate the feasibility and acceptability of a protocol for middle- and older-aged Black women with depressive symptoms.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 29, 2021
CompletedFirst Posted
Study publicly available on registry
April 8, 2021
CompletedStudy Start
First participant enrolled
September 14, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 2, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
April 2, 2023
CompletedOctober 19, 2023
October 1, 2023
7 months
March 29, 2021
October 17, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Recruitment, completion, and retention rates of participants
80 percent recruitment, 80 percent completion, and 75 percent retention
16 weeks
Assess Acceptability according to the Theoretical Framework of Acceptability
Qualitative assessment of Acceptability. The interview guide will be organized according to the constructs of the Theoretical Framework of Acceptability. Methodological conventions of qualitative description will be used to analyze the data.
16 weeks
Secondary Outcomes (3)
Changes in Perceived Stress Scale (PSS) from baseline at 8 weeks and 16 weeks
baseline, 8 weeks, 16 weeks
Changes in Positive and Negative Affect Schedule (PANAS) Scale from baseline at 8 weeks and 16 weeks
baseline, 8 weeks, 16 weeks
Changes in Acceptance and Action Questionnaire II (AAQ-II) from baseline at 8 weeks and 16 weeks
baseline, 8 weeks, 16 weeks
Study Arms (2)
Group 1 Intervention, Weeks 1-8
EXPERIMENTALDuring Weeks 1-8, Group 1 receives the Intervention and Group 2 receives no treatment.
Group 2 Intervention, Weeks 9-16
ACTIVE COMPARATORDuring Weeks 9-16, Group 2 receives the Intervention and Group 1 receives no treatment.
Interventions
The intervention is an 8-week, therapeutically-informed protocol.
Eligibility Criteria
You may qualify if:
- Identify as Black or African American
- Identify as female
- Age 40 years and older
- Community-dwelling
- Self-report of experiencing depressive symptoms
- Ability to commit to the 8-week intervention
- Access to Zoom
- Speak and read English
You may not qualify if:
- Have a diagnosis of bipolar, but is not taking medication for the condition
- Experiencing psychosis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of California, Los Angeles
Los Angeles, California, 90095, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kia Skrine Jeffers, PhD, RN, PHN
University of California, Los Angeles
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
March 29, 2021
First Posted
April 8, 2021
Study Start
September 14, 2022
Primary Completion
April 2, 2023
Study Completion
April 2, 2023
Last Updated
October 19, 2023
Record last verified: 2023-10